Welcome to our dedicated page for Argan SEC filings (Ticker: AGX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Argan, Inc. (NYSE: AGX) is a Delaware corporation whose common stock is listed on the New York Stock Exchange, and it files periodic and current reports with the U.S. Securities and Exchange Commission. This SEC filings page brings together Argan’s Forms 10-K and 10-Q, as well as its frequent Form 8-K current reports, which disclose material events such as financial results, major project contracts and dividend declarations.
In its Form 8-K filings, Argan reports items like quarterly earnings releases under results of operations and financial condition, regular quarterly cash dividend announcements, and significant EPC contract awards received by subsidiaries such as Gemma Power Systems and Atlantic Projects Company. These filings also confirm key corporate details, including Argan’s state of incorporation, the AGX trading symbol and its New York Stock Exchange listing.
For investors and analysts, Argan’s annual reports on Form 10-K and quarterly reports on Form 10-Q provide more comprehensive information on segment performance, project backlog, risk factors and accounting policies, while current reports on Form 8-K highlight specific developments between reporting periods. Filings may also describe how new EPC contracts, full notices to proceed and backlog additions affect the company’s future activity.
On this page, AI-powered tools summarize lengthy SEC documents, highlight the main points from Argan’s 10-K and 10-Q filings, and explain the significance of individual 8-K items, such as dividend changes or large contract awards. Users can also review insider and executive-related filings like Form 4, along with proxy materials, to gain additional insight into Argan’s governance and equity activity.
ARGAN INC director Peter W. Getsinger reported multiple share movements involving the company’s common stock. On April 29, 2026, he sold 3,000 shares in an open‑market transaction at an average price of $628.36 per share, leaving 6,847 shares held directly after this sale.
On the same date, he also made a bona fide gift of 500 shares of common stock. In addition to his direct holdings, he reports indirect ownership of 133 shares held in a custody account for a child and 267 shares held in a children's trust.
ARGAN INC director Lisa Larroque Alexander sold common stock in an open-market trade. On April 29, 2026, the reporting person sold 350 shares of Argan’s common stock at an average price of $630.58 per share.
After this transaction, the director directly owned 350 shares of Argan common stock, according to the Form 4. The filing reports no derivative securities, so the activity relates only to non-derivative common stock holdings.
ARGAN INC director William F. Leimkuhler reported open-market sales of 5,800 shares of Argan common stock. On April 28, 2026, he sold 5,000 shares directly at an average price of $617.41 per share.
On the same date, the Emily K. Leimkuhler Trust and the Elizabeth K. Leimkuhler Trust, for which he serves as trustee, each sold 400 shares in open-market transactions, at reported prices of $621.14 and $618.61 per share. Following these sales, Leimkuhler holds 36,495 shares directly, and each trust holds 500 shares indirectly attributed to him as trustee.
ARGAN INC director Jeffrey John Ronald Jr. reported an open-market sale of the company’s common stock. On April 27, 2026, he sold 2,698 shares at an average price of $664.84 per share, leaving 2,000 shares held directly and 8,000 shares held indirectly through a John R. Jeffrey IRA.
Argan Inc. submitted a Form 144 notice reporting proposed or recent secondary sales of common stock. The filing shows a reported sale by William Leimkuhler of 8,444 shares for $5,053,538 on 04/13/2026. The filing also lists securities tied to earlier transactions: 5,000 shares from a 07/20/2020 stock option exercise and two 400-share open-market purchase entries dated 10/07/2013 and 10/08/2013.
Argan, Inc. (AGX) reported a Form 144 notice indicating proposed insider sales. The filing lists 4,698 shares under "Securities To Be Sold" (dated 04/21/2026) and shows three reported sales during the prior three months: 5,000 (01/27/2026), 4,556 (03/31/2026), and 3,636 (04/21/2026).
The transactions are linked to option exercise/equity grant activity and identify Charles Schwab & Co. as the broker. The filing provides contact details for the selling party, John R. Jeffrey, Jr., and lists the exchange as NYSE.
Argan, Inc. ownership disclosure: First Trust Portfolios L.P., First Trust Advisors L.P. and The Charger Corporation jointly report beneficial ownership of 821,295 shares of Common stock, representing 5.89% as of 03/31/2026, filed on a Schedule 13G.
The filing states shared voting power 791,353 and shared dispositive power 821,295; the registrants disclaim sole beneficial ownership and describe holdings held through unit investment trusts and advisory accounts.
ARGAN INC executive Charles Edwin Collins IV, CEO of Gemma, reported option exercises and share sales in April 2026. He exercised stock options to acquire a total of 13,568 shares of common stock at exercise prices ranging from $33.81 to $148.72 per share.
On April 20, 2026, he exercised an option for 2,500 shares at $39.47 per share and sold 2,500 shares at $610 per share. On April 21, 2026, he exercised additional options totaling 11,068 shares and sold 11,068 shares at an average price of $621.61 per share. Following these transactions, he directly holds 30,320 shares of ARGAN common stock.
ARGAN INC director Jeffrey John Ronald Jr. reported an option exercise and share sale. On April 21, 2026, he exercised a stock option for 5,000 shares of common stock at $37.13 per share using a net settle method, receiving 4,698 shares of common stock.
That same day, he sold 3,636 shares of common stock in open-market transactions at an average price of $615.40 per share. After these transactions, he held 4,698 shares directly and 8,000 shares indirectly through a John R. Jeffrey IRA.